At SfN 2024, neuroscientists converge to share groundbreaking research, fostering interdisciplinary connections and advancing the understanding of the brain.
Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative Alzheimer's disease treatment approaches.
Under Rhiannon White's leadership, Clue is transforming menstrual health tracking into a powerful tool for research and improved reproductive health outcomes.
Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing critical needs in cardiovascular health.
Online pharmacies must now conduct in-person consultations before dispensing weight-loss medications, ensuring safe and appropriate use of high-risk drugs.
Prof. Dr. Inge Herrmann discusses her innovative work in healthcare, focusing on a reversible hydrogel implant that could transform gynecological treatments.
Dr. Pascale Allotey advocates for comprehensive maternal health policies, stressing the importance of women's voices in shaping effective healthcare solutions.
CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making it more accessible and efficient.